Probing the Depths for Diagnostic Performance of Biparametric and Multiparametric MRI for Prostate Cancer Detection- A Meta-Analysis

BackgroundProstate cancer is a malignancy that originates in the prostate gland,and can vary in aggressiveness, often requiring a combination of diagnostic methods and imaging for accurate detection and management. In an attempt to ensure timely diagnosis and prevent complications, the choice of the right diagnostic modality becomes crucial. MRI has gained prominence in the diagnosis of prostate cancer. MRI aids prostate cancer diagnosis by pinpointing suspicious areas for in-depth investigation and guiding precise biopsies, enhancing accuracy. It also informs treatment plans by visualizing tumour extent and assists in monitoring disease progression during active surveillance. The purpose of this meta-analysis is to ascertain the accuracy of MRI in diagnosing prostate cancer. MethodologyMedical literature was comprehensively searched and reviewed without restrictions to particular study designs, or publication dates using PubMed, Cochrane Library, and Google Scholar databases for all relevant literature. The extraction of necessary data proceeded after specific inclusion and exclusion criteria were applied. In this Meta-Analysis, A total of 47 RCTs with 13,211 subjects were selected for comparing Multiparametric MRI vs. Gold Standard and A total of 23 RCTs with 3440 subjects were selected for comparing Biparametric MRI vs Gold Standard. Two writers independently assessed the calibre of each study as well as the use of the Cochrane tool for bias risk apprehension. The statistical software packages RevMan (Review Manager, version 5.3), SPSS (Statistical Package for the Social Sciences, version 20), and Excel in Stata 14 were used to perform the statistical analyses. ResultsWe calculated the sensitivity and specificity of multiparametric as well as biparametric MRI. The Multiparametric MRI demonstrates a sensitivity of 0.84 (95% confidence interval: 0.83 - 0.85) and specificity of 0.69 (95% confidence interval: 0.68 - 0.70). Meanwhile, Biparametric MRI shows a sensitivity of 0.85 (95% confidence interval: 0.84 - 0.86) and specificity of 0.71 (95% confidence interval: 0.69 - 0.73). ConclusionIn conclusion, both Multiparametric MRI and Biparametric MRI exhibit high sensitivity values of 0.84 and 0.85, respectively, indicating their ability to accurately detect prostate cancer. MRI is a robust diagnostic tool for prostate cancer due to its high-resolution imaging and multiparametric approach. It enables targeted biopsies, informs treatment plans, and aids in active surveillance.